Mehdi Abbasnejad
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mehdi Abbasnejad has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
Saeed Esmaeili-Mahani
Department of Biology, Faculty of Sciences, Shahid Bahonar University of Kerman, 76169-14111 Kerman, Iran
13 shared publications- Saeed Esmaeili-Mahani
Department of Biology, Faculty of Sciences, Shahid Bahonar University of Kerman, Kerman, Iran
12 shared publications - Maryam Raoof
Department of Orofacial Pain and Dysfunction, Academic Centre for Dentistry Amsterdam (ACTA), University of Amsterdam and Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
7 shared publications Razieh Kooshki
Department of Biology, Faculty of Sciences, Lorestan University, 68151-44316 Khorramabad, Iran
5 shared publicationsMahnaz Zamyad
Department of Biology, Faculty of Sciences, Shahid Bahonar University of Kerman, 76169-14111 Kerman, Iran
4 shared publicationsMaryam Raoof
Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran; Department of orofacial pain and dysfunction, Academic center for dentistry of Amsterdam (ACTA), University of Amsterdam and Vrije Universities Amsterdam, Amsterdam, The Netherlands
4 shared publications
Latest Publications
- Open Access
- 11 September 2026
- Published by Taylor & Francis in Stress
- Vol. 29 (1)
Chronic stress persistently upregulates hippocampal histamine H1 and H2 receptors: dissociation from behavioral recovery with fluoxetine and exercise
Chronic stress is a major aetiological factor in depressive disorders and induces enduring neurobiological alterations within limbic circuits that regulate affective processing (McEwen, 2007; Willn...
- 11 September 2026
- Published by Taylor & Francis in Stress
- Vol. 29 (1)
Open AccessChronic stress persistently upregulates hippocampal histamine H1 and H2 receptors: dissociation from behavioral recovery with fluoxetine and exercise
Chronic stress is a major aetiological factor in depressive disorders and induces enduring neurobiological alterations within limbic circuits that regulate affective processing (McEwen, 2007; Willn...
- 31 May 2026
- Published by Taylor & Francis in Nutritional Neuroscience
- p. 1-19
Stress-induced changes in dietary amino acid preferences and 5-HT2A receptor gene expression in acute and chronic stress models
Deficiencies in neurotransmitter precursors are associated with stress and depression. This study evaluated amino acid preferences in rats subjected to acute and chronic stress, along with the gene expression of the serotonin receptor 5-HT2A (5-HT2AR) in the basolateral amygdala (BLA) of rats to assess the detrimental effects of stress on them. Seventy adult male Wistar rats were used in behavioral and molecular experiments. The forced swimming test (FST) and chronic unpredictable stress (Cus) protocols were employed to induce acute and chronic stress. For both experiments, the animals were randomly divided into five groups (n = 7): Control, acute stress (As), As + fluoxetine, Cus, and Cus + fluoxetine. Amino acid preferences, including tryptophan, tyrosine, and histidine, were assessed. Moreover, 5-HT2AR expression in the BLA was evaluated using real-time PCR. Chronic stress produced a pronounced increase in total food intake (approximately two-to-three-fold relative to controls). In contrast, acute stress elicited a strong, and specific preference for tyrosine-enriched food, which accounted for the majority of total intake, while consumption of tryptophan- and histidine-enriched diets was markedly reduced. Administration of fluoxetine greatly reduced overall food intake and altered amino acid preferences in both stress models. Gene expression of 5-HT2AR was markedly elevated in both stress groups, an effect that was completely reversed by fluoxetine treatment. Dietary amino acids preference and 5-HT2AR expression may be involved in the pathophysiology of depression. These findings may inform future preventive or therapeutic interventions.
- 31 May 2026
- Published by Taylor & Francis in Nutritional Neuroscience
- p. 1-19
Stress-induced changes in dietary amino acid preferences and 5-HT2A receptor gene expression in acute and chronic stress models
Deficiencies in neurotransmitter precursors are associated with stress and depression. This study evaluated amino acid preferences in rats subjected to acute and chronic stress, along with the gene expression of the serotonin receptor 5-HT2A (5-HT2AR) in the basolateral amygdala (BLA) of rats to assess the detrimental effects of stress on them. Seventy adult male Wistar rats were used in behavioral and molecular experiments. The forced swimming test (FST) and chronic unpredictable stress (Cus) protocols were employed to induce acute and chronic stress. For both experiments, the animals were randomly divided into five groups (n = 7): Control, acute stress (As), As + fluoxetine, Cus, and Cus + fluoxetine. Amino acid preferences, including tryptophan, tyrosine, and histidine, were assessed. Moreover, 5-HT2AR expression in the BLA was evaluated using real-time PCR. Chronic stress produced a pronounced increase in total food intake (approximately two-to-three-fold relative to controls). In contrast, acute stress elicited a strong, and specific preference for tyrosine-enriched food, which accounted for the majority of total intake, while consumption of tryptophan- and histidine-enriched diets was markedly reduced. Administration of fluoxetine greatly reduced overall food intake and altered amino acid preferences in both stress models. Gene expression of 5-HT2AR was markedly elevated in both stress groups, an effect that was completely reversed by fluoxetine treatment. Dietary amino acids preference and 5-HT2AR expression may be involved in the pathophysiology of depression. These findings may inform future preventive or therapeutic interventions.
- Open Access
- 12 March 2026
- Published by MRE Press in Journal of Oral & Facial Pain and Headache
- Vol. 40 (2) , 43-53
Alpha-pinene modulates feeding behavior and hypothalamic orexin-A expression in a rat model of painful temporomandibular disorder
Background: Temporomandibular disorders (TMDs) are common conditions involving the temporomandibular joint (TMJ) and masticatory muscles, often presenting with pain and impaired orofacial function. Painful TMD can disrupt jaw motor activities, including chewing and feeding behavior, reflecting alteration in muscle performance and central neuroregulation. The hypothalamic neuropeptide orexin A integrates pain, arousal, and energy balance and may be involved in these disturbances. This study examined whether intracerebroventricular (ICV) administration of alpha-pinene, an anti-inflammatory monoterpene, could modulate pain-related impairments in feeding behavior and orexin A expression in a rat model of inflammatory TMD. Methods: TMJ inflammation was induced in male Wistar rats via Complete Freund’s Adjuvant (CFA) injection. Rats received ICV alpha-pinene (0.1, 0.2, or 0.4 µg/rat). Feeding behavior parameters—including meal frequency, duration, and total intake—were recorded with an automated monitoring system as functional readouts of masticatory muscle activity during food processing. Anxiety-like behavior was evaluated using the elevated plus maze, and hypothalamic orexin A expression was assessed by immunohistochemistry. Results: CFA-treated rats showed reduced pain thresholds, anxiety-like behavior, and impaired feeding behavior, including fewer meals, shorter feeding duration, and reduced intake. Alpha-pinene, particularly at 0.4 µg/rat, significantly improved these behavioral outcomes and restored hypothalamic orexin A expression compared with untreated CFA rats. Conclusions: Alpha-pinene mitigated pain-related disruptions in feeding behavior and restored hypothalamic orexin A expression in a rat model of TMJ inflammation. These findings highlight the interplay between orofacial pain, altered oral motor function, and central neuroregulation. The observed behavioral improvements suggest that alpha-pinene may offer therapeutic benefits for managing functional impairments associated with both muscular and joint-related TMD pain, supporting its potential as a candidate for integrative TMD management.
- 12 March 2026
- Published by MRE Press in Journal of Oral & Facial Pain and Headache
- Vol. 40 (2) , 43-53
Open AccessAlpha-pinene modulates feeding behavior and hypothalamic orexin-A expression in a rat model of painful temporomandibular disorder
Background: Temporomandibular disorders (TMDs) are common conditions involving the temporomandibular joint (TMJ) and masticatory muscles, often presenting with pain and impaired orofacial function. Painful TMD can disrupt jaw motor activities, including chewing and feeding behavior, reflecting alteration in muscle performance and central neuroregulation. The hypothalamic neuropeptide orexin A integrates pain, arousal, and energy balance and may be involved in these disturbances. This study examined whether intracerebroventricular (ICV) administration of alpha-pinene, an anti-inflammatory monoterpene, could modulate pain-related impairments in feeding behavior and orexin A expression in a rat model of inflammatory TMD. Methods: TMJ inflammation was induced in male Wistar rats via Complete Freund’s Adjuvant (CFA) injection. Rats received ICV alpha-pinene (0.1, 0.2, or 0.4 µg/rat). Feeding behavior parameters—including meal frequency, duration, and total intake—were recorded with an automated monitoring system as functional readouts of masticatory muscle activity during food processing. Anxiety-like behavior was evaluated using the elevated plus maze, and hypothalamic orexin A expression was assessed by immunohistochemistry. Results: CFA-treated rats showed reduced pain thresholds, anxiety-like behavior, and impaired feeding behavior, including fewer meals, shorter feeding duration, and reduced intake. Alpha-pinene, particularly at 0.4 µg/rat, significantly improved these behavioral outcomes and restored hypothalamic orexin A expression compared with untreated CFA rats. Conclusions: Alpha-pinene mitigated pain-related disruptions in feeding behavior and restored hypothalamic orexin A expression in a rat model of TMJ inflammation. These findings highlight the interplay between orofacial pain, altered oral motor function, and central neuroregulation. The observed behavioral improvements suggest that alpha-pinene may offer therapeutic benefits for managing functional impairments associated with both muscular and joint-related TMD pain, supporting its potential as a candidate for integrative TMD management.
- 9 November 2025
- Published by Knowledge E DMCC in Iranian Journal of Allergy, Asthma and Immunology
- Vol. 24 (6) , 818-833
Abscisic Acid Regulates Immune-inflammatory Responses to Induce Neuroprotection in Spinal Cord Injury: Insights from Gene Expression and Network Analysis
Spinal cord injuries (SCI) lead to complex primary and secondary damage that disrupts neural function. Current treatments are often insufficient and unable to fully repair spinal cord injuries, highlighting the urgent need for new medicines and innovative therapies. This study aimed to evaluate the therapeutic potential of abscisic acid (ABA) in SCI by examining its effects on immune-inflammatory genes’ expression in rats. This phytohormone possesses anti-inflammatory and neuroprotective properties, rendering it a potential agent for reducing secondary damage following spinal cord injury. Additionally, we performed protein-protein interaction (PPI), pathway enrichment, functional annotation, and gene ontology (GO) analyses to gain a comprehensive understanding of the functions of the affected genes. Based on the results, SCI led to changes in the expression of immune/inflammation-related genes in rats. However, the administration of ABA alleviated the effects. ABA downregulated proinflammatory genes (IL-6, IL-1β, MCP, TLR2, TLR4) and neural signaling components (NMDA, AMPA, NK1R), while upregulating adrenergic receptors (ADRA1A, ADRB1) and a gamma-aminobutyric acid receptor (AGBRA2). PPI analysis identified FOS, IL-1β, IL-6, MMP9, and TLR4 as crucial nodes in the network, exhibiting the highest degree of interaction. Functional analyses revealed potential impacts on cellular responses, metabolic processes, and synapse-associated extracellular matrix components. Notably, these genes were enriched in inflammatory signaling pathways according to KEGG analysis. These findings suggest that ABA has a significant modulatory effect on gene expression following SCI, particularly in reducing inflammation and immune responses, thereby highlighting its potential as a novel therapeutic agent for SCI.
- 9 November 2025
- Published by Knowledge E DMCC in Iranian Journal of Allergy, Asthma and Immunology
- Vol. 24 (6) , 818-833
Abscisic Acid Regulates Immune-inflammatory Responses to Induce Neuroprotection in Spinal Cord Injury: Insights from Gene Expression and Network Analysis
Spinal cord injuries (SCI) lead to complex primary and secondary damage that disrupts neural function. Current treatments are often insufficient and unable to fully repair spinal cord injuries, highlighting the urgent need for new medicines and innovative therapies. This study aimed to evaluate the therapeutic potential of abscisic acid (ABA) in SCI by examining its effects on immune-inflammatory genes’ expression in rats. This phytohormone possesses anti-inflammatory and neuroprotective properties, rendering it a potential agent for reducing secondary damage following spinal cord injury. Additionally, we performed protein-protein interaction (PPI), pathway enrichment, functional annotation, and gene ontology (GO) analyses to gain a comprehensive understanding of the functions of the affected genes. Based on the results, SCI led to changes in the expression of immune/inflammation-related genes in rats. However, the administration of ABA alleviated the effects. ABA downregulated proinflammatory genes (IL-6, IL-1β, MCP, TLR2, TLR4) and neural signaling components (NMDA, AMPA, NK1R), while upregulating adrenergic receptors (ADRA1A, ADRB1) and a gamma-aminobutyric acid receptor (AGBRA2). PPI analysis identified FOS, IL-1β, IL-6, MMP9, and TLR4 as crucial nodes in the network, exhibiting the highest degree of interaction. Functional analyses revealed potential impacts on cellular responses, metabolic processes, and synapse-associated extracellular matrix components. Notably, these genes were enriched in inflammatory signaling pathways according to KEGG analysis. These findings suggest that ABA has a significant modulatory effect on gene expression following SCI, particularly in reducing inflammation and immune responses, thereby highlighting its potential as a novel therapeutic agent for SCI.
- 10 June 2025
- Published by Egyptian Knowledge Bank in Microbes and Infectious Diseases
Variations in Interleukin-12 and Growth Differentiation Factor-15 among COVID-19-infected, recovered, and healthy individuals
Background: COVID-19 causes varied symptoms, affecting multiple systems, including immune and hematological functions. Severe inflammation, driven by cytokines, often worsens outcomes. This study compared blood markers (IL-12, GDF-15, zinc) among COVID-19-infected, recovered, and healthy individuals, assessing their link to disease severity. Methods: A case-control study at Samarra General Hospital, Iraq (2022), included 100 participants: 40 healthy controls and 60 COVID-19 patients (30 severe, 30 recovered). IL-12 and GDF-15 were measured via ELISA. Results: GDF-15 (males: 721.4 ± 5 ng/L; females: 736.6 ± 4 ng/L), IL-12 (males: 692.4 ± 4 ng/L; females: 599 ± 4 ng/L), and WBC (3.872 × 10⁹/L) significantly increased (p < 0.001, except WBC p < 0.01) in infected/recovered groups. Zinc decreased (infected: p < 0.001; recovered: p < 0.05). RBC, PCV, MCV, and Hb showed no significant differences, but MCH, MCHC, lymphocytes, and platelets decreased (p < 0.05). Conclusion: COVID-19 triggers lasting changes in inflammatory markers, growth factors, and blood cell parameters.
- 10 June 2025
- Published by Egyptian Knowledge Bank in Microbes and Infectious Diseases
Variations in Interleukin-12 and Growth Differentiation Factor-15 among COVID-19-infected, recovered, and healthy individuals
Background: COVID-19 causes varied symptoms, affecting multiple systems, including immune and hematological functions. Severe inflammation, driven by cytokines, often worsens outcomes. This study compared blood markers (IL-12, GDF-15, zinc) among COVID-19-infected, recovered, and healthy individuals, assessing their link to disease severity. Methods: A case-control study at Samarra General Hospital, Iraq (2022), included 100 participants: 40 healthy controls and 60 COVID-19 patients (30 severe, 30 recovered). IL-12 and GDF-15 were measured via ELISA. Results: GDF-15 (males: 721.4 ± 5 ng/L; females: 736.6 ± 4 ng/L), IL-12 (males: 692.4 ± 4 ng/L; females: 599 ± 4 ng/L), and WBC (3.872 × 10⁹/L) significantly increased (p < 0.001, except WBC p < 0.01) in infected/recovered groups. Zinc decreased (infected: p < 0.001; recovered: p < 0.05). RBC, PCV, MCV, and Hb showed no significant differences, but MCH, MCHC, lymphocytes, and platelets decreased (p < 0.05). Conclusion: COVID-19 triggers lasting changes in inflammatory markers, growth factors, and blood cell parameters.
- 17 May 2025
- Published by Elsevier in Neuroscience Letters
- Vol. 859-861, 138269
The expression of connexin 36 and 43 in animal models of trait and state anxiety
- 17 May 2025
- Published by Elsevier in Neuroscience Letters
- Vol. 859-861, 138269
The expression of connexin 36 and 43 in animal models of trait and state anxiety
- Open Access
- 16 March 2025
- Published by Maad Rayan Publishing Company in Addiction & Health
- Vol. 17 (1) , 1-7
Investigation of the Inhibitory Effect of Naringin on the Development of Morphine Physical Dependency in Male Rats
Background: Morphine dependence is a significant concern because of its potential for inducing addiction and adverse withdrawal symptoms. Naringin, a flavonoid compound found in citrus fruits, has shown promise in various pharmacological activities, including analgesic and anti-inflammatory effects. However, its potential role in inhibiting or reducing morphine dependence has not been extensively investigated yet. This study aimed to determine whether naringin can inhibit or reduce physical morphine dependence in rats. Methods: Morphine dependence was induced in rats through chronic injection of the drug for 7 days. Also, different doses of naringin (10, 25, and 50 mg/kg) were administered 15 minutes prior to morphine injection in three experimental groups. The effect of naringin pretreatment on drug withdrawal-associated symptoms, including body weight, jumping, abdominal contraction, grooming, ptosis, diarrhea, and teeth chattering, was evaluated. Finding: The animals experiencing morphine dependence exhibited significant body weight loss. However, administration of naringin before morphine injection prevented this loss by 50%. Also, drug withdrawal symptoms such as jumping, abdominal contraction, grooming, diarrhea, and teeth chattering were significantly increased in the rats. Interestingly, the prescription of naringin significantly reduced these symptoms. Ptosis was observed in all rats receiving morphine, while naringin did not significantly affect this symptom. Furthermore, the inhibitory effect of naringin on morphine physical dependence was found to be dose-dependent. Conclusion: Naringin pretreatment demonstrated potential in inhibiting or reducing physical morphine dependence in rats. These findings suggest that naringin may have therapeutic potential in managing morphine dependence and associated withdrawal symptoms.
- 16 March 2025
- Published by Maad Rayan Publishing Company in Addiction & Health
- Vol. 17 (1) , 1-7
Open AccessInvestigation of the Inhibitory Effect of Naringin on the Development of Morphine Physical Dependency in Male Rats
Background: Morphine dependence is a significant concern because of its potential for inducing addiction and adverse withdrawal symptoms. Naringin, a flavonoid compound found in citrus fruits, has shown promise in various pharmacological activities, including analgesic and anti-inflammatory effects. However, its potential role in inhibiting or reducing morphine dependence has not been extensively investigated yet. This study aimed to determine whether naringin can inhibit or reduce physical morphine dependence in rats. Methods: Morphine dependence was induced in rats through chronic injection of the drug for 7 days. Also, different doses of naringin (10, 25, and 50 mg/kg) were administered 15 minutes prior to morphine injection in three experimental groups. The effect of naringin pretreatment on drug withdrawal-associated symptoms, including body weight, jumping, abdominal contraction, grooming, ptosis, diarrhea, and teeth chattering, was evaluated. Finding: The animals experiencing morphine dependence exhibited significant body weight loss. However, administration of naringin before morphine injection prevented this loss by 50%. Also, drug withdrawal symptoms such as jumping, abdominal contraction, grooming, diarrhea, and teeth chattering were significantly increased in the rats. Interestingly, the prescription of naringin significantly reduced these symptoms. Ptosis was observed in all rats receiving morphine, while naringin did not significantly affect this symptom. Furthermore, the inhibitory effect of naringin on morphine physical dependence was found to be dose-dependent. Conclusion: Naringin pretreatment demonstrated potential in inhibiting or reducing physical morphine dependence in rats. These findings suggest that naringin may have therapeutic potential in managing morphine dependence and associated withdrawal symptoms.
- 28 September 2024
- Published by Elsevier in Archives of Oral Biology
- Vol. 169, 106100
Impact of temporomandibular disorder on food preference behavior in adult male rats
- 28 September 2024
- Published by Elsevier in Archives of Oral Biology
- Vol. 169, 106100
Impact of temporomandibular disorder on food preference behavior in adult male rats
- Open Access
- 1 February 2024
- Published by Negah Scientific Publisher in Research in Molecular Medicine
- Vol. 12 (1) , 9-22
Identification of Critical Genes and Underlying Diseases in Early-onset Alzheimer’s Disease by Bioinformatics Approach
Background: Alzheimer’s disease (AD) is a neurodegenerative and multifactorial disorder. Investigating the key genes and metabolic pathways is important for understanding the mechanisms of AD. This study aimed to analyze the gene network and biological pathways of AD using bioinformatics approaches. Materials and Methods: AD-related genes were identified, and a gene network ...
- 1 February 2024
- Published by Negah Scientific Publisher in Research in Molecular Medicine
- Vol. 12 (1) , 9-22
Open AccessIdentification of Critical Genes and Underlying Diseases in Early-onset Alzheimer’s Disease by Bioinformatics Approach
Background: Alzheimer’s disease (AD) is a neurodegenerative and multifactorial disorder. Investigating the key genes and metabolic pathways is important for understanding the mechanisms of AD. This study aimed to analyze the gene network and biological pathways of AD using bioinformatics approaches. Materials and Methods: AD-related genes were identified, and a gene network ...
- 19 January 2024
- Published by Galenos Yayinevi in Turkish Journal of Pharmaceutical Sciences
- Vol. 20 (6) , 374-379
Methyl Jasmonate Modulates Feeding Behaviors and Hypothalamic Expression of the Orexin 1 Receptor in Rats
Active plant ingredients have been successfully used in modern medicine to control appetite and energy hemostasis. This study was designed to evaluate the efficacy of the phytohormone methyl jasmonate (MJ) on food-related behaviors in rats. Adult male Wistar rats were randomly divided into different groups (7 rats) and infused intracerebroventricularly (i.c.v.) with MJ vehicle (DMSO) or MJ (2.5, 5 and 10 μg/rat). Then, the individual rats were placed in an automated open field-like apparatus to assess a 12-h food-related activity in light and dark times. After behavioral tests, immunofluorescence staining of the orexin 1 receptor (Orx1R) was studied in the hypothalamus of rats. MJ (2.5, 5, and 10 μg/rat) administration significantly decreased food intake in the light and dark phases compared with the control group. Moreover, all the MJ-treated groups exhibited a decrease in visits to food containers at the light and dark times (p < 0.001). In addition, rats infused with MJ at 5 μg and 10 μg spent less time in the ports of food containers in the light and dark phases in comparison with control rats. Time in zone-related to food and locomotor activity was significantly decreased in the MJ (5 μg) groups during the light time and in all MJ-injected groups in the dark time. Moreover, hypothalamic expression of Orx1R in rats treated with MJ (5 μg) was significantly lower as compared to the control group. Overall, the results indicated the potential of MJ to modulate feeding-related behavior and Orx1R expression in the hypothalamus of rats.
- 19 January 2024
- Published by Galenos Yayinevi in Turkish Journal of Pharmaceutical Sciences
- Vol. 20 (6) , 374-379
Methyl Jasmonate Modulates Feeding Behaviors and Hypothalamic Expression of the Orexin 1 Receptor in Rats
Active plant ingredients have been successfully used in modern medicine to control appetite and energy hemostasis. This study was designed to evaluate the efficacy of the phytohormone methyl jasmonate (MJ) on food-related behaviors in rats. Adult male Wistar rats were randomly divided into different groups (7 rats) and infused intracerebroventricularly (i.c.v.) with MJ vehicle (DMSO) or MJ (2.5, 5 and 10 μg/rat). Then, the individual rats were placed in an automated open field-like apparatus to assess a 12-h food-related activity in light and dark times. After behavioral tests, immunofluorescence staining of the orexin 1 receptor (Orx1R) was studied in the hypothalamus of rats. MJ (2.5, 5, and 10 μg/rat) administration significantly decreased food intake in the light and dark phases compared with the control group. Moreover, all the MJ-treated groups exhibited a decrease in visits to food containers at the light and dark times (p < 0.001). In addition, rats infused with MJ at 5 μg and 10 μg spent less time in the ports of food containers in the light and dark phases in comparison with control rats. Time in zone-related to food and locomotor activity was significantly decreased in the MJ (5 μg) groups during the light time and in all MJ-injected groups in the dark time. Moreover, hypothalamic expression of Orx1R in rats treated with MJ (5 μg) was significantly lower as compared to the control group. Overall, the results indicated the potential of MJ to modulate feeding-related behavior and Orx1R expression in the hypothalamus of rats.